STTK
Shattuck Labs, Inc.
NASDAQ · Healthcare · Biotechnology · US
$6.79
−2.44%Margins
Gross margin
-750.9%
EBITDA margin
-4845.4%
EBIT margin
-5578.7%
Net margin
-5256.8%
FCF margin
-4124.0%
-24.9%
Return on equity
-23.8%
Return on assets
-26.1%
Return on invested capital
0.01x
Asset turnover
-$41.0M
Cash from operations
$0.63
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026